Mortality rates in people dually infected with HIV-1/2 and those infected with either HIV-1 or HIV-2: A systematic review and meta-analysis

AIDS

Volumn 28, Issue 4, 2014, Pages 549-558

  Prince, Puck D ^a   Matser, Amy ^a,b   Van Tienen, Carla ^c   Whittle, Hilton C ^d   Schim Van Der Loeff, Maarten F ^a,e  

^a DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

HIV 1; HIV 2; HIV dual; Meta analysis; Mortality; Systematic review

Indexed keywords

ADOLESCENT; ADULT; AGED; COINFECTION; FEMALE; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; MALE; MIDDLE AGED; MORTALITY; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84893302277     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/01.SPC.0000432532.87841.78     Document Type: Review

References (52)

1. WHO, UNAIDS, UNICEF. Global HIV/AIDS response. Epidemic update and health sector progress towards Universal Access. Progress report 2011. Geneva, Switzerland: WHO Press; 2011.
2. Poulsen AG, Kvinesdal B, Aaby P, Molbak K, Frederiksen K, Dias F, et al. Prevalence of and mortality from human immunodeficiency virus type 2 in Bissau, West Africa. Lancet 1989; 1:827-831.
3. Poulsen AG, Aaby P, Gottschau A, Kvinesdal BB, Dias F, Molbak K, et al. HIV-2 infection in Bissau, West Africa, 1987-1989: Incidence, prevalences, and routes of transmission. J Acquir Immune Defic Syndr 1993; 6:941-948.
4. Wilkins A, Ricard D, Todd J, Whittle H, Dias F, Paulo Da SA. The epidemiology of HIV infection in a rural area of Guinea-Bissau. AIDS 1993; 7:1119-1122.
5. Da Silva ZJ, Oliveira I, Andersen A, Dias F, Rodrigues A, Holmgren B, et al. Changes in prevalence and incidence of HIV-1, HIV-2 and dual infections in urban areas of Bissau, Guinea-Bissau: Is HIV-2 disappearing AIDS 2008; 22:1195-1202.
6. Norrgren H, Andersson S, Biague AJ, Da Silva ZJ, Dias F, Naucler A, et al. Trends and interaction of HIV-1 and HIV-2 in Guinea-Bissau, west Africa: No protection of HIV-2 against HIV-1 infection. AIDS 1999; 13:701-707.
7. Mansson F, Alves A, Silva ZJ, Dias F, Andersson S, Biberfeld G, et al. Trends of HIV-1 and HIV-2 prevalence among pregnant women in Guinea-Bissau, West Africa: Possible effect of the civil war 1998 1999. Sex Transm Infect 2007; 83:463-467.
8. Schim Van Der Loeff M, Awasana A, Sarge-Njie R, Van Der Sande M, Jaye A, Sabally S, et al. Sixteen years of HIV surveillance in a West African research clinic reveals divergent epidemic trends of HIV-1 and HIV-2. Int J Epidemiol 2006; 35:1322-1328.
9. Adjorlolo-Johnson G, De Cock KM, Ekpini E, Vetter KM, Sibailly T, Brattegaard K, et al. Prospective comparison of mother-tochild transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast. JAMA 1994; 272:462-466.
10. Gilbert PB, McKeague IW, Eisen G, Mullins C, Gueye-Ndiaye A, Mboup S, et al. Comparison of HIV-1 and HIV-2 infectivity from a prospective cohort study in Senegal. Stat Med 2003; 22:573-593.
11. Kanki PJ, Travers KU, Mboup S, Hsieh CC, Marlink RG, Gueye-Ndiaye A, et al. Slower heterosexual spread of HIV-2 than HIV-1. Lancet 1994; 343:943-946.
12. Marlink R, Kanki P, Thior I, Travers K, Eisen G, Siby T, et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 1994; 265:1587-1590.
13. Schim Van Der Loeff M, Jaffar S, Aveika AA, Sabally S, Corrah T, Harding E, et al. Mortality of HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients in a clinic-based cohort in The Gambia. AIDS 2002; 16:1775-1783.
14. Guyader M, Emerman M, Sonigo P, Clavel F, Montagnier L, Alizon M. Genome organization and transactivation of the human immunodeficiency virus type 2. Nature 1987; 326: 662-669.
15. Martinez-Steele E, Awasana AA, Corrah T, Sabally S, Van Der Sande M, Jaye A, et al. Is HIV-2-induced AIDS different from HIV-1-associated AIDS Data from a West African clinic. AIDS 2007; 21:317-324.
16. Rowland-Jones S. A winding road towards an HIV vaccine. Eur J Immunol 2008; 38:13-14.
17. Hamel DJ, Sankale JL, Eisen G, Meloni ST, Mullins C, Gueye-Ndiaye A, et al. Twenty years of prospective molecular epidemiology in Senegal: Changes in HIV diversity. AIDS Res Hum Retroviruses 2007; 23:1189-1196.
18. Van Tienen C, Schim Van Der Loeff M, Peterson I, Cotten M, Andersson S, Holmgren B, et al. HTLV-1 and HIV-2 infection are associated with increased mortality in a rural West African community. PLoS One 2011; 6:e29026.
19. Poulsen AG, Aaby P, Larsen O, Jensen H, Naucler A, Lisse IM, et al. 9-year HIV-2-associated mortality in an urban community in Bissau, west Africa. Lancet 1997; 349:911-914.
20. Esbjornsson J, Mansson F, Kvist A, Isberg PE, Nowroozalizadeh S, Biague AJ, et al. Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection. N Engl J Med 2012; 367:224-232.
21. Van Tienen C, Schim Van Der Loeff M, Whittle H. Effect of HIV-2 infection on HIV-1 disease progression. N Engl J Med 2012; 367:1961-1963.
22. Holmgren B, Da SZ, Vastrup P, Larsen O, Andersson S, Ravn H, et al. Mortality associated with HIV-1, HIV-2, and HTLV-I single and dual infections in a middle-aged and older population in Guinea-Bissau. Retrovirology 2007; 4:85.
23. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Int J Surg 2010; 8:336-341.
24. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. J Clin Epidemiol 2008; 61:344-349.
25. Wells G, Shea B, OConnell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 3rd Symposium on Systematic Reviews: Beyond the basics. Improving quality and impact2000.
26. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557-560.
27. Harris RJ, Bradburn MJ, Deeks JJ, Harbord RM, Altman DG, Sterne JAC. Metan: Fixed-and random-effects meta-analysis. Stata J 2008; 8:3-28.
28. Gustafson P, Gomes VF, Vieira CS, Samb B, Naucler A, Aaby P, et al. Clinical predictors for death in HIV-positive and HIVnegative tuberculosis patients in Guinea-Bissau. Infection 2007; 35:69-80.
29. Norrgren H, Bamba S, Da Silva ZJ, Koivula T, Andersson S. Higher mortality in HIV-2/HTLV-1 co-infected patients with pulmonary tuberculosis in Guinea-Bissau, West Africa, compared to HIV-2-positive HTLV-1-negative patients. Int J Infect Dis 2010; 14 (Suppl 3):e142-e147.
30. Kassim S, Sassan-Morokro M, Ackah A, Abouya LY, Digbeu H, Yesso G, et al. Two-year follow-up of persons with HIV-1-and HIV-2-associated pulmonary tuberculosis treated with shortcourse chemotherapy in West Africa. AIDS 1995; 9:1185-1191.
31. Hansmann A, Schim Van Der Loeff MF, Kaye S, Awasana AA, Sarge-Njie R, ODonovan D, et al. Baseline plasma viral load and CD4 cell percentage predict survival in HIV-1-and HIV-2-infected women in a community-based cohort in The Gambia. J Acquir Immune Defic Syndr 2005; 38:335-341.
32. Whittle H, Morris J, Todd J, Corrah T, Sabally S, Bangali J, et al. HIV-2-infected patients survive longer than HIV-1-infected patients. AIDS 1994; 8:1617-1620.
33. Schim Van Der Loeff MF, Larke N, Kaye S, Berry N, Ariyoshi K, Alabi A, et al. Undetectable plasma viral load predicts normal survival in HIV-2-infected people in a West African village. Retrovirology 2010; 7:46.
34. Alabi AS, Jaffar S, Ariyoshi K, Blanchard T, Schim Van De Loeff MF, Awasana AA, et al. Plasma viral load, CD4 cell percentage, HLA and survival of HIV-1, HIV-2, and dually infected Gambian patients. AIDS 2003; 17:1513-1520.
35. ODonovan D, Ariyoshi K, Milligan P, Ota M, Yamuah L, Sarge-Njie R, et al. Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia. MRC/Gambia Government/University College London Medical School working group on mother-child transmission of HIV. AIDS 2000; 14:441-448.
36. Travers K, Mboup S, Marlink R, Gueye-Nidaye A, Siby T, Thior I, et al. Natural protection against HIV-1 infection provided by HIV-2. Science 1995; 268:1612-1615.
37. Ariyoshi K, Schim Van Der Loeff M, Sabally S, Cham F, Corrah T, Whittle H. Does HIV-2 infection provide cross-protection against HIV-1 infection AIDS 1997; 11:1053-1054.
38. Greenberg AE. Possible protective effect of HIV-2 against incident HIV-1 infection: Review of available epidemiological and in vitro data. AIDS 2001; 15:2319-2321.
39. Schim Van Der Loeff M, Aaby P, Aryioshi K, Vincent T, Awasana AA, Da CC, et al. HIV-2 does not protect against HIV-1 infection in a rural community in Guinea-Bissau. AIDS 2001; 15:2303-2310.
40. Al-Harthi L, Owais M, Arya SK. Molecular inhibition of HIV type 1 by HIV type 2: Effectiveness in peripheral blood mononuclear cells. AIDS Res Hum Retroviruses 1998; 14:59-64.
41. Arya SK, Gallo RC. Human immunodeficiency virus (HIV) type 2-mediated inhibition of HIV type 1: A new approach to gene therapy of HIV-infection. Proc Natl Acad Sci USA 1996; 93:4486-4491.
42. Kokkotou EG, Sankale JL, Mani I, Gueye-Ndiaye A, Schwartz D, Essex ME, et al. In vitro correlates of HIV-2-mediated HIV-1 protection. Proc Natl Acad Sci USA 2000; 97:6797-6802.
43. Rappaport J, Arya SK, Richardson MW, Baier-Bitterlich G, Klotman PE. Inhibition of HIV-1 expression by HIV-2. J Mol Med (Berl) 1995; 73:583-589.
44. Nkengasong JN, Kestens L, Ghys PD, Koblavi-Deme S, Otten RA, Bile C, et al. Dual infection with human immunodeficiency virus type 1 and type 2: Impact on HIV type 1 viral load and immune activation markers in HIV-seropositive female sex workers in Abidjan, Ivory Coast. AIDS Res Hum Retroviruses 2000; 16:1371-1378.
45. De Silva TI, Van Tienen C, Rowland-Jones SL, Cotten M. Dual infection with HIV-1 & HIV-2: Double trouble of destructive interference HIV Therapy 2010; 4:305-323.
46. Van Tienen C, Schim Van Der Loeff MS, Zaman SM, Vincent T, Sarge-Njie R, Peterson I, et al. Two distinct epidemics: The rise of HIV-1 and decline of HIV-2 infection between 1990 and 2007 in rural Guinea-Bissau. J Acquir Immune Defic Syndr 2010; 53:640-647.
47. Ariyoshi K, Cham F, Berry N, Harding E, Sabally S, NGom PT, et al. Diagnosis of HIV-1/2 dual infection using dilution analysis of type-specific antibody. AIDS 1998; 12:2504-2505.
48. Tedder RS, OConnor T, Hughes A, Njie H, Corrah T, Whittle H. Envelope cross-reactivity in Western blot for HIV-1 and HIV-2 may not indicate dual infection. Lancet 1988; 2:927-930.
49. De Cock KM, Porter A, Kouadio J, Maran M, Lafontaine MF, Gershy-Damet GM, et al. Cross-reactivity on western blots in HIV-1 and HIV-2 infections. AIDS 1991; 5:859-863.
50. Andersson S, Da SZ, Norrgren H, Dias F, Biberfeld G. Field evaluation of alternative testing strategies for diagnosis and differentiation of HIV-1 and HIV-2 infections in an HIV-1 and HIV-2-prevalent area. AIDS 1997; 11:1815-1822.
51. Nkengasong JN, Maurice C, Koblavi S, Kalou M, Bile C, Yavo D, et al. Field evaluation of a combination of monospecific enzyme-linked immunosorbent assays for type-specific diagnosis of human immunodeficiency virus type 1 (HIV-1) and HIV-2 infections in HIV-seropositive persons in Abidjan, Ivory Coast. J Clin Microbiol 1998; 36:123-127.
52. Egger M, Davey SG, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ 1997; 315:629-634.